Efficacy and Safety of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B

Clinical trial NCT01760122 · COMPLETED

Trial details

NCT number: NCT01760122
Sponsor: Xiamen Amoytop Biotech Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2013-03-01
Primary completion: 2015-07-01
Enrollment: 820

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.